Skip to main content

Table 3 Outcomes for Thoracic Endovascular Aortic Repair with Unrevascularized and Revascularized left subclavian artery, Carotid-Subclavian Bypass, and F-TEVAR

From: Left subclavian artery revascularization in thoracic endovascular aortic repair: single center’s clinical experiences from 171 patients

Variables Overall Unrevascularized (n = 28) Revascularized (n = 143) P1 value iP2 value
CSB (n = 100) F-TEVAR (n = 43)
30-day outcomes, n 171 28 100 43   
 Mortality (N, %) 1, 0.6% 1, 3.6% 0, 0% 0, 0% 0.164 _
 Stroke (N, %) 2, 1.2% 0, 0% 2, 2.0% 0, 0% 1 1
 Left upper extremity ischemia (N, %) 2, 1.2% 0, 0% 2, 2% 0, 0% 1 1
 Spinal cord ischemia (N, %) 5, 2.9% 3, 10.7% 1, 1.0% 1, 2.3% 0.032* 0.512
Midterm outcomes, n 167 26 100 41   
 Mortality (N, %) 10, 6.0% 2, 7.7% 8, 8% 0, 0% 1 0.143
 Stroke (N, %) 9, 5.4% 3, 11.5% 4, 4.0% 2, 4.9% 0.299 1
 Left upper extremity ischemia (N, %) 12, 7.2% 4, 15.4% 6, 6.0% 2, 4.9% 0.177 1
 Spinal cord ischemia (N, %) 0, 0% 0, 0% 0, 0% 0, 0% _ _
  1. P1 value, unrevascularied versus revascularized
  2. P2 value, CSB versus F-TEVAR
  3. *Statistically significant values